Evaluation of Surrogate Risk Factors for Severe Progression of COVID-19 in Tobacco Smoking Sub-Population and its Possible Amelioration by Immune Modulators. GJMR. 2022;22(K2):67-79. Accessed January 30, 2026. https://medicalresearchjournal.org/index.php/GJMR/article/view/102185